Curriculum Vitae DR.

Shankar Siva, MBBS, FRANZCR

E D U C A T I O N

Higher Education

The University of Melbourne; Doctorate of Philosophy

2012-present

Fellowship:

The Royal Australian and New Zealand

College of Radiologists

2007-2012

Tertiary Education: The University of Melbourne; Bachelor Medicine /

Bachelor of Surgery
W O R K

1998-2003

E X P E R I E N C E

Internship, Barwon Health, Geelong Hospital

2004

House Medical Officer - BARWON HEALTH, GEELONG HOSPITAL

Radiation Oncology Registrar - GEELONG
Radiation Oncology Registrar PETER MAC
Chief Radiation Oncology Registrar PETER MAC
RADIATION ONCOLOGY FELLOW, PETER MAC
2010-2011s
RESEARCH STAFF SPECIALIST, RADIATION ONCOLOG
Y 2010-2011s

2006
2007

X E C U T I V E

2008-2009
2010-2011
2011
2012 - present

U M M A R Y

Dr Siva is a Radiation Oncologist and NHMRC Scholar at the Peter MacCallum

Cancer Centre in Melbourne. His major research interests are in high-tech radiation
delivery and radiation biology. He is the lead clinician of the stereotactic body
radiotherapy program at the Peter MacCallum Cancer Centre, and coordinates the first
dedicated Stereotactic Ablative Body Radiotherapy (SABR) clinic in Australia. He
published the first original research using the SABR technique in Australia. He is the
Chair Elect of the Radiation Oncology Research Committee (RORC) of the Royal
Australian and New Zealand College of Radiologists, represents radiation oncology on
the Scientific Advisory Committee (SAC) of the Australasian Lung Cancer Trials
Group (ALTG), and is on the renal cell committee of the Australian and New Zealand
Urogenital and Prostate (ANZUP) cancer trials group. He is the principal investigator
of multiple radiotherapy clinical trials of SABR in the context of lung, kidney and
prostate malignancies. He has been the chief principal investigator of 6 investigator
initiated prospective studies to date, and has received approximately AUD $1.1 million
of research/grant funding.
A C A D E M I C

R O L E S

/ R E S P O N S I B I L I T I E S

Alternate National Project Coordinator IAEA (International Atomic Energy Association)

Australia: - project RAS6065 Strengthening the Application of Stereotactic Body
Radiation Therapy to Improve Cancer Treatment 2012 - present
Journal reviewer: Lancet Oncology, Journal of Medical Imaging and Radiation Oncology,
Practical Radiation Oncology, Tumori, SpringerPlus, BMC Cancer
Faculty Radiation Oncology Research Committee member (RORC), the Royal Australian
and New Zealand College of Radiation Oncology 2012 - present

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , M B B S , F R A N Z C R

P A G E 1

 Management Advisory Committee (MAC) executive member, the Australasian Lung Trials
Group (ALTG) 2012 2014
Scientific Advisory Committee (SAC) executive member, the Australasian Lung Trials
Group (ALTG) 2014 - present
Renal Cell Committee member for Australia and New Zealand Urogenital and Prostate
(ANZUP) 2012 - present
Lead clinician of the Stereotactic Ablative Body Radiotherapy (SABR) clinic at the Peter
MacCallum Cancer Centre, responsibility for establishing the SABR service at the Peter
Mac
Organizing Committee Member of the 17th International Conference on the Use of
Computers in Radiation Therapy (ICCR), 2013
ASM Abstract reviewer RANZCR 2013, ANZUP 2013
Organizing Committee Member of Australia and New Zealand Urogenital and Prostate
(ANZUP) trials group ASM 2014
Organizing Committee Member of IAEA (International Atomic Energy Association)
Australasia stereotactic workshop 2015
NHMRC project grant round 2012/2014: external assessor
TransTasman Radiation Oncology (TROG) Genitourinary Group committee 2014 TransTasman Radiation Oncology (TROG) Lung Group committee 2014 - present
Faculty of Radiation Oncology Lung Interest Group (FROLIC), executive member 2014 present

D U C A T I O N

C T I V I T I E S

National Nursing Short Courses - Invited teacher for Radiotherapy Module Two biannual teaching course (May, Oct) 2013, 2014
Specialist Certificate of Clinical Oncology, University of Melbourne, 2013 / 2014
invited teacher, Research in Radiotherapy
Victranet Phase II Radiation Oncology Mock Examiner 2012, 2013
Victranet Radiation Oncology tutor / lecturer 2012 present
Convenor of the Peter Mac SABR symposium 2014 - training for tripartite members in
SABR representatives from Australia and New Zealand

I N V E S T I G A T O R
C L I N I C A L
T R I A L S

I N I T I A T E D
P R O S P E C T I V E
R I N C I P A L
I N V E S T I G A T O R

( P

1. HREC 14/05 Project Title: Stereotactic Hypofractionated body radiosurgery for

Oligometastatic Renal cell Tumours upfront, with Systemic Targeted agents On
Progression (SHORTSTOP)
2. HREC/14/PMCC/2: Project Title: Stereotactic Ablative Fractionated Radiotherapy versus
Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial
(SAFRON II)

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 2

3. HREC 11/106 Project Title: A pilot study of Focal Ablative STereotactic RAdiosurgery
for Cancers of the Kidney or isolated adrenal metastases (FASTRACK)
4. HREC 12/162 Project Title: A Pilot Study of patients with Oligometastases from Prostate
cancer treated with Stereotactic Ablative Body Radiosurgery (POPSTAR)
5. HREC 11/64 Project Title: A Prospective Feasibility Study of Gallium-68 Ventilation and
Perfusion PET/CT During and After Radiotherapy in Patients with Non-Small Cell Lung
Cancer (GALLIPET V/QRT)
6. HREC 10/80: Project Title: A prospective pilot study of Stereotactic Ablative Frameless
Radiosurgery for Oligometastatic Neoplasia of the lung (SAFRON)
M A N U S C R I P T

P U B L I C A T I O N S

1.
Siva S, Talman P, Broad A, Norden S. Paraneoplastic encephalomyelitis associated
with motor neuron disease causing respiratory failure in the setting of occult small cell lung
carcinoma. Asia Pacific Journal of Clinical Oncology 2008;4(2): 118-21.
2.
Siva S, MacManus M, Ball D. Stereotactic Radiotherapy for Pulmonary
Oligometastases: A Systematic Review. Journal of Thoracic Oncology 2010;5(7): 1091.
3.
Siva S, Narayan K, Bernshaw D, Gill S, Hicks RJ, Herschtal A. Impact of PostTherapy Positron Emission Tomography on Prognostic Stratification and Surveillance After
Chemoradiotherapy for Cervical Cancer. Cancer 2011,117:3981, DOI: 10.1002/cncr.25991
4.
Gill S, Younie S, Rolfo A, Siva et al. Cost Minimization Analysis: Kilovoltage
Imaging With Automated Repositioning Versus Electronic Portal Imaging In Image Guided
Radiotherapy For Prostate Cancer, Volume 24, Issue 8, October 2012, Pages e93e99
5.
Siva S, Chesson B, Aarons Y, Clements N, Kron T, MacManus M, Ball D,
Implementation of a Lung Radiosurgery Program: Technical Considerations and Quality
Assurance in an Australian Institution. Journal of Medical Imaging and Radiation Volume
56, Issue 3, pages 354361, June 2012
6.
Siva S, Shaw M, B Chesson, S Gill, Ball D "Analysis of the Impact of Chest Wall
Constraints on Eligibility for a Randomized Trial of Stereotactic Body Radiotherapy of
Peripheral Stage I Non-Small Cell Lung Cancer" , Journal of Medical Imaging and
Radiation 12/2012 56(6):654-60
7.
Siva S, Pham D, Corcoran N, Gill S, Foroudi F, A systematic review of
stereotactic radiotherapy ablation for primary renal cell carcinoma, British Journal of BJU
International. 2012, 110(11 Pt B):E737-43
8.
Taylor M, Yeo APham D, Franich R, Siva S, T Kron The validity of 'dosewarping': Comment on "It is not appropriate to 'deform' dose along with deformable image
registration in adaptive radiotherapy" [Med. Phys. 39, 6531-6533 (2012)], Med. Phys. 40,
017102 (2013)
9.
Clements, N., T. Kron, R. Franich, L. Dunn, P. Roxby, Y. Aarons, B. Chesson, S.
Siva, D. Duplan, and D. Ball. "The effect of irregular breathing patterns on internal target
volumes in four-dimensional CT and cone-beam CT images in the context of stereotactic
lung radiotherapy." Medical Physics 40 (2013): 021904.
10.
Siva S, Byrne K, Seel M, Bressel M, Jacobs D, Callahan J, Laing J, MacManus P,
Hicks J, 18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in the
Staging of Merkel Cell Carcinoma: A 15-year Institutional Experience, Journal of Nuclear
Medicine, 54 (8), 1223-1229.

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 3

11.
Siva S, Callahan J, MacManus M, Hicks J, Ball D, Abscopal effects after
conventional and stereotactic lung irradiation of non-small cell lung cancer, Journal of
Thoracic Oncology 8.8 (2013): e71-e72.
12.
Callahan J, Kron T, Schneider-Kolsky M..Siva S, Aarons Y, Binns D, Hicks R,
Validation of a 4D-PET maximum intensity projection (MIP) for delineation of an internal
target volume (ITV), ), International Journal of Radiation Oncology* Biology* Physics
(2013).
13.
Bardia T, Gill S, Siva S, Tai KH, Lim Joon M, Foroudi F Ten-year results of
quality assurance in radiotherapy chart round, BMC Health Services Research 2013,
13:148
14.
UJ Yeo, ML Taylor, T Kron, D Pham, S Siva and RD Franich, Potential
dosimetric benefit of dose-warping based 4D planning compared to conventional 3D
planning in liver stereotactic body radiotherapy (SBRT), 2013 J. Phys.: Conf. Ser. 444
012071, doi:10.1088/1742-6596/444/1/012071
15.
Gill, S, Pham D, Dang K, Bressel M, Kron T, Siva S, Tran P, Tai KH, Foroudi F,
Plan of the Day Selection for Online Image-Guided Adaptive Post-prostatectomy
Radiotherapy", Radiotherapy and Oncology 2013, 107 (2), pp. 165
16.
Pham D, Kron T, Foroudi F, Siva S, Effect of different breathing patterns in the
same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell
carcinoma: A case study, Medical Dosimetry 2013, 38 (3) , pp. 304
http://dx.doi.org/10.1016/j.meddos.2013.03.001
17.
Siva S, T Devereux, T Kron, et al., Vacuum Immobilization Reduces Tumour
Excursion and Minimises Intrafraction Error in a Cohort Study of Stereotactic Ablative
Body Radiotherapy for Pulmonary Metastases, Journal of medical imaging and radiation
oncology (2013)

18.
D.Pham, T.Kron, F.Foroudi, M.Schneider Kolsky and S.Siva A Review of
Kidney Motion under Free, Deep and Forced-Shallow Breathing Conditions: Implications
for Stereotactic Ablative Body Radiotherapy Treatment Technology in cancer research &
treatment (2013).
19.
Siva S, Pham D, Gill S, Bressel M, Dang K, Devereux T, Kron T and Foroudi F,
An Analysis of Respiratory Induced Renal Motion on Four- Dimensional Computed
Tomography and its Implications for Stereotactic Kidney Radiotherapy, Radiation
Oncology 8.1 (2013): 248
20.
Martin, O. A., Anderson, R. L., Russell, P. A., Cox, R.A , Ivashkevich, A.,
Swierczak, A., Doherty, J., Jacobs D., Smith J.,Siva S., Daly P., Ball D.L., & MacManus,
M. P. (2013). Mobilization of Viable Tumor Cells Into the Circulation During Radiation
Therapy. International Journal of Radiation Oncology* Biology* Physics. 2013.
21.
Callahan J, Hofman M, Siva S, Kron T, Schneider MW, Binns D, Eu P, Hicks RJ,
High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory
gated (4-D) PET/CT, Eur J Nucl Med Mol Imaging (2013): 1-7
22.
Kipritidis, J., S. Siva, J. Callahan, M. Hofman, and P. Keall. Validating and
improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using 68Galabeled nanoparticles Med. Phys. 41, 011910 (2014); http://dx.doi.org/10.1118/1.4856055
23.
Hardcastle, N., Clements, N., Chesson, B., Aarons, Y., Cramb, J., Siva, S., ... &
Kron, T. (2014). Results of patient specific quality assurance for patients undergoing
stereotactic ablative radiotherapy for lung lesions. Australasian Physical & Engineering
Sciences in Medicine, 1-8.

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 4

24.

Gill, S., Isiah, R., Adams, R., Dang, K., Siva, S., Tai, K. H., ... & Foroudi, F.
Conventional margins not sufficient for post-prostatectomy prostate bed coverage: An
analysis of 477 cone-beam computed tomography scans. Radiotherapy and Oncology 110.2
(2014): 235-239.
25.
Pham, D., T. Kron, C. StylesS. Siva. "The Use of Dual Vacuum Stabilization
Device to Reduce Kidney Motion for Stereotactic Radiotherapy Planning." Technology in
cancer research & treatment (2014).
26.
Loh, Jasmin, Ian D. Davis, Jarad M. Martin, and Shankar Siva. "Extracranial
oligometastatic renal cell carcinoma: current management and future directions." Future
Oncology 10, no. 5 (2014): 761-774.
27.
Gunjur, Ashray, Cuong Duong, David Ball, and Shankar Siva. "Surgical and
ablative therapies for the management of adrenal oligometastasesA systematic review."
Cancer treatment reviews (2014)
28.
Hanna GG, Siva S, Plumridge N, Solomon B and Ball DL (2014) Preoperative
chemotherapy for non-small-cell lung cancer. The Lancet 384: 232-233.
29.
Kothari, G., Foroudi, F., Gill, S., Corcoran, N. M., & Siva, S. (2014). Outcomes of
stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A
systematic review.: Acta Oncologica, 2014 (0), 1-10.
30.
S. Siva, M.P. Macmanus, R.F. Martin, O.A. Martin, Abscopal effects of radiation
therapy: a clinical review for the radiobiologist, Cancer letters 2015;356:82-90.
31.
32.
Yao HHI, Hong MKH, Corcoran NM, Siva S and Foroudi F (2014) Advances in
local and ablative treatment of oligometastasis in prostate cancer. Asia-Pacific Journal of
Clinical Oncology, epub 08/2014
33.
Tan T-J, Siva S, Foroudi F, et al. (2014) Stereotactic body radiotherapy for
primary prostate cancer: A systematic review. Journal of Medical Imaging and Radiation
Oncology, 58: 601611. doi: 10.1111/1754-9485.12213
34.
Siva S, Callahan J, Kron T, Martin O, MacManus M, Ball D, Hicks R, Hofman M,
A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during
and after radiotherapy in patients with non-small cell lung cancer, BMC Cancer 2014,
14:740
35.
S.Siva, M MacManus, T. Kron, N. Best, J Smith, P. Lobachevsky, D. Ball, O. Martin, A
Pattern of Early Radiation-Induced Inflammatory Cytokine Expression is Associated with Lung
Toxicity in Patients with Non-Small Cell Lung Cancer, PLoS ONE 2014 Oct 7;9(10):e109560. doi:
10.1371/journal.pone.0109560
36. Rose, M., Siva, S., Ball, D., Irving, L. B., & Steinfort, D. P. (2014). Bronchoscopic Delivery
of Lipiodol as a Fiducial Marker in Lung Tumors Before Radiotherapy. Journal of Thoracic
Oncology, 9(10), 1579-1583.
37. Steinfort, D., Siva S, Kron T, Chee R, Ruben J, Ball D, and Irving L. "Multimodality guidance
for accurate bronchoscopic insertion of fiducial markers." Journal of Thoracic Oncology
(2014).
38.
UJ Yeo, M Taylor, J Supple, S Siva, T Kron, D. Pham, R Franich "Evaluation of
dosimetric misrepresentations from 3D conventional planning of liver SBRT using 4D
deformable dose integration" Journal of Applied Clinical Medical Physics 2014, 15(6):1-14
39.
PA Jackson III, F Foroudi, D Pham, MS Hofman, N Hardcastle, J Callahan, T Kron
and S Siva Timeline of Radiation-Induced Kidney Function Loss after Stereotactic
Ablative Body Radiotherapy of Renal Cell Carcinoma as evaluated by serial 99mTc-DMSA
SPECT/CT, Radiation Oncology 2014, 9:253
C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 5

40.
T Devereux, D Pham, T Kron, F Foroudi, J Supple and S Siva - A Planning Study
Investigating Dual Gated Volumetric Arc Stereotactic Treatment of Primary Renal Cell
Carcinoma, accepted Medical Dosimetry Oct 2014
41.
S Siva, Foroudi, Farshad, Ball, David, Kirby Kerryn, Hannah Caine, Pham Daniel,
Kron Tomas, Te Marvelde Luc, Deborah Whalley, Mark Stevens, MacManus Michael,
Thomas Eade, Comparison of Single-Fraction and Multi-Fraction Stereotactic
Radiotherapy for Patients with FDG-PET Staged Pulmonary Oligometastases, accepted,
Nov 6th 2014, Clinical Oncology
42.
K Tan. S Siva (senior author) Predictors of respiratory-induced lung tumour
motion measured on 4DCT accepted Clinical Oncology
43.
J Callahan, T Kron, S Siva et al, Geographic miss of lung tumours due to
respiratory motion: A comparison of 3D vs 4D PET/CT defined target volumes, accepted,
Radiation Oncology
44.
S Siva, T Devereux, D Ball et al. Ga-68 MAA Perfusion 4D-PET/CT Scanning
Allows for Functional Lung Avoidance Using Conformal Radiation therapy Planning,
accepted Technology in Cancer Research and Treatment (TCRT) 2014
45.
B Sawyer, E Pun S Siva, CT perfusion imaging in response assessment of
pulmonary metastases undergoing stereotactic ablative radiotherapy, accepted JMIRO
Nov 21st 2014
46.
M. Taylor, J. Supple, S. Keehan, UJ Yeo, S Siva, T Kron, D Pham, A Haworth, R
Franich The importance of quasi-4D path-integrated dose accumulation for more accurate
risk estimation in stereotactic liver radiotherapy, pending minor revision 30th October,
2014, Technology in Cancer Research
47.
Predictors of respiratory induced lung tumour motion measured on CT, Tan et
al, (S Siva as senior author), pending minor revision, Clinical Oncology
48.
N Hardcastle, T Kron. S Siva (senior author) Accuracy and utility of
deformable image registration in 68-Ga 4D PET/CT assessment of pulmonary perfusion
changes during and after lung radiotherapy, pending major revision, IJROBP 2014
49.
M Hofman, D Binns, V Joshnton et al. Ga-68 EDTA PET/CT imaging and plasma
clearance for glomerular filtration rate (GFR) quantification: comparison to conventional
Cr-51 EDTA, pending minor revision Journal of Nuclear Medicine

O O K

H A P T E R S

1.
Martin OA, Nowsheen S, Siva S, Aziz K, Hatzi VI, Georgakilas AG. Chapter 7 inflammation and oxidative DNA damage: A dangerous synergistic pathway to cancer. In:
Preedy V, editor Cancer. San Diego: Academic Press; 2014. pp. 63-74. Elsevier ISBN:
978-0-12-405205-5
S

E L E C T E D

E F E R E E D
A B S T R A C T
U B L I C A T I O N S

1. S. Siva, B. Chesson, . D. Ball et al: Submillimetre accuracy is achieved when using

stereotactic radiosurgery with a dedicated immobilization system for patients with lung

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 6

oligometastases, Journal of Thoracic Oncology. 6(6):S903-S1688, June 2011. doi:

10.1097/01.JTO.0000399290.73317.eb
2. Siva, S., et al., Post-therapy Positron Emission Tomography may Obviate the Need for
Conventional Follow-up in Patients Receiving Chemoradiation for Advanced Cervical
Cancer. International Journal of Gynecological Cancer. 21(12):S1-S1372, October
2011. doi: 10.1097/IGC.0b013e318235bd2
3. Siva, S., et al. "OC-0125 Long-Term Outcomes Of A Prospective Study Of PostTherapy PET After Chemoradiation Of Cervical Cancer." Radiotherapy and
Oncology 103 (2012): S49.
4. Clements, N, Kron, T. Siva, S, Duplan, D & Ball, D 2012, The effect of irregular
breathing patterns on internal target volumes in four-dimensional CT and cone-beam
CT images in the context of stereotactic lung radiotherapy, conference paper for
EPI2k12, Sydney, NSW, March 12-14, 2012, in press
5. Siva, S., et al. "FDG-PET Scanning has a High Impact on the Management of Patients
With Merkel Cell Carcinoma." International Journal of Radiation Oncology* Biology*
Physics 84.3 (2012): S136.
6. Siva, S., et al. "Routine Follow-up Rarely Detects Disease Recurrence After a Complete
Response on FDG-PET in Patients With Locally Advanced Cervical
Cancer." International Journal of Radiation Oncology* Biology* Physics 84.3 (2012):
S20.
7. Siva, S., et al. "Analysis of Potential Surrogates for Kidney Motion Verification
Imaging and its Implications for Stereotactic Radiation Therapy of the
Kidney."International Journal of Radiation Oncology* Biology* Physics 84.3 (2012):
S423.
8. Siva, S., et al. "Technical Considerations And Preliminary Experience Of A Pilot Study
Of Gallium-68 VQ 4D-PET/CT In Lung Radiotherapy." Journal Of Thoracic Oncology.
Vol. 7. No. 9. 530 Walnut St, Philadelphia, Pa 19106-3621 Usa: Lippincott Williams &
Wilkins, 2012.
9. Unjin Yeo, Michael Taylor, Tomas Kron, Daniel Pham, Shankar Siva and Rick
Franich. Dosimetric differences between conventional 3D treatment planning and 4D
dose warping cumulative treatment planning: Patient study in the case of liver SBRT.
Australas. Phys. Eng. Sci. Med. 36 (2013) 112. Abstract of a paper presented at the
Engineering and Physical Sciences in Medicine (EPSM) Conference, Gold Coast,
December 2 6, 2012.
10. Devereux, T., Kron, T., Foroudi, F., MacManus, M., Pham, D., Chesson, B. & Siva, S.
A Personalized Immobilization Cradle Facilitates Robust Immobilization And
Reproducibility During Stereotactic Radiosurgery Of Pulmonary Metastases. Journal Of Thoracic Oncology 2012 (Vol. 7, No. 9, pp. S163-S163).
11. M.K. HONG, N.M. CORCORAN , S. SIVA and F. FOROUDI: Treatment of prostate
cancer oligometastases: a systematic review BJU Int, 111:13, (2013), doi
10.1111/bju.12069
12. S. SIVA, N. CORCORAN, D. PHAM et al, stereotactic radiosurgery for primary
renal cell carcinoma: early findings of the FASTRACK pilot study BJU Int, 111:13,
(2013), doi 10.1111/bju.12069
13. Callahan J, Siva S., et al. Deformable image registration for mapping functional
imaging data between multiple image sets, Australas Phys Eng Sci Med (2013) 36:65
141

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 7

14. Hardcastle N., Clements N., Siva S., et al. Quality assurance for individual patients
undergoing stereotactic radiotherapy, Australas Phys Eng Sci Med (2013) 36:65141
15. Hardcastle, N., Clements, N., Chesson, B., Aarons, Y., Cramb, J., Siva, S., ... & Kron,
T. (2014). Results of patient specific quality assurance for patients undergoing
stereotactic ablative radiotherapy for lung lesions. Australasian Physical &
Engineering Sciences in Medicine, 1-8
16. Siva, S., Pham, D., Kron, T., Devereux, T., Corcoran, N. M., Bressel, M., ... & Foroudi,
F. (2013, July). EARLY FINDINGS OF A PROSPECTIVE CLINICAL TRIAL OF
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PRIMARY RENAL
CELL CARCINOMA. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol.
9, pp. 43-44).
17. K Tan, R Thomas, N Hardcastle, D Pham, T Kron, F Foroudi, D Ball, S Siva, A study
of respiratory-induced tumour motion based on anatomical lung location using 4DCT in
lung cancer patients
18. Hong, M. K., N. M. Corcoran, S. Siva, and F. Foroudi. "Treatment of prostate cancer
oligometastases: a systematic review." In BJU INTERNATIONAL, vol. 111, pp. 94-94.
111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2013
19. T.Kron, D. Steinfort, N. Hardcastle, B. Chesson, S. Siva, L. Irving, D. Ball, Image
Guidance For Extracranial Stereotactic Radiotherapy Of Lung Cancers Using
Endobronchially Implanted Fiducial Markers, EPSM 2013
20. Kipritidis, J., S. Siva, J. Callahan, M. Hofman, and P. Keall. "TU-A-WAB-08: Strong
Evidence for Physiologic Correlation of 4D-CT Ventilation Imaging with
Respiratory-Correlated Gallium 68 PET/CT in Humans." Medical Physics 40, no. 6
(2013): 424-424.
21. Shankar Siva, Rod Hicks, Brooke Sawyer, et al., MO17.01 Response Assessment Of
Stereotactic Ablative Body Radiotherapy (SABR) For Pulmonary Metastases: Utility Of
4D-FDG-PET And CT Perfusion, 15th World Conference on Lung Cancer. Journal of
Thoracic Oncology, 2013. 8: p. S357 10.1097/01.JTO.0000438438.14562.c8.
22. Nicholas Hardcastle, Natalie Clements, Shankar Siva, et al. Patient Specific Quality
Assurance For Lung Cancer Stereotactic Ablative Body Radiotherapy 15th World
Conference on Lung Cancer. Journal of Thoracic Oncology, 2013. 8: p. S1139
23. Daniel P. Steinfort, Shankar Siva, Tomas Kron et al., Preliminary Experience In
Bronchoscopic Placement And In-Treatment Imaging Of Two Different Fiducial
Markers For Guidance Of Lung Cancer Radiation 15th World Conference on Lung
Cancer. Journal of Thoracic Oncology, 2013. 8: p. S1141
24. David Ball, Sarah Everitt, Tomas Kron, Shankar Siva, Michael Macmanus et al.
Staging And Early Response Assessment In Combined Modality Therapy For
NSCLC
25. Shankar Siva, Michael Hofman, Thomas Devereux et al. MO23.01 Four-Dimensional
Gallium-68 Perfusion PET/CT Scans Can Improve Radiotherapy Planning Through
Functional Avoidance Of Lung. 15th World Conference on Lung Cancer. Journal of
Thoracic Oncology, 2013. 8: p. S395 10.1097/01.JTO.0000438438.14562.c8.
26. Shankar Siva, Pavel Lobachevsky, Nickala Best et al., DNA Damage Response
During Curative Radiotherapy Of Non-Small Cell Lung Cancer: In-Vivo Biodosimetry
With Peripheral Blood Lymphocytes And Systemic Effects Measured In Hair
Follicles. 15th World Conference on Lung Cancer. Journal of Thoracic Oncology,
2013. 8: p. S779 10.1097/01.JTO.0000438438.14562.c8
C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 8

27. F.Hegi-Johnson, S.Siva, M. Foote et al. Improving Access To Stereotactic Ablative

Body Radiotherapy (SABR) For Lung Cancer Patients In Asia. 15th World Conference
on Lung Cancer. Journal of Thoracic Oncology, 2013. 8: p. S1130
28. S Gill, T Devereaux, K Dang, S Siva, et al., Respiratory gating and four-dimensional
computed tomography for stereotactic ablative body radiotherapy (SABR) in kidney
cancer assessed by 3-Tesla cinematic magnetic resonance imaging, Journal of Medical
Imaging and Radiation Oncology (2013) 57, pp51
29. S Siva, M Hofman, T Devereux, et al. Four-dimensional Gallium-68
ventilation/perfusion
30. PET/CT scans can improve radiotherapy planning through functional avoidance of
lung Journal of Medical Imaging and Radiation Oncology (2013) 57, pp52
31. K Byrne, M Seel and S Siva, The utility of 18F-FDG PET imaging in staging,
response assessment, and re-staging of Merkel cell carcinoma Journal of Medical
Imaging and Radiation Oncology (2013) 57, pp61
32. S Siva, Mario Sarmiento, B Chesson et al. Stereotactic radiosurgery for pulmonary
oligometastases Journal of Medical Imaging and Radiation Oncology (2013) 57, pp109
33. K Tan, R Thomas, N Hardcastle. and S Siva. A study of respiratory-induced tumour
motion based on anatomical lung location using 4DCT in lung cancer patients, Journal
of Medical Imaging and Radiation Oncology (2013) 57, pp110
34. Kothari, G., Foroudi, F., Corcoran, N. M., & Siva, S. (2013, July). OUTCOMES OF
STEREOTACTIC RADIOTHERAPY FOR CRANIAL AND EXTRACRANIAL
METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW. In AsiaPacific Journal Of Clinical Oncology (Vol. 9, Pp. 38-38).
35. Siva, S., Corcoran, N., Pham, D., Cox, A., Grills, R., Brook, N., ... & Foroudi, F. (2013,
April). Feasibility and tolerability of stereotactic radiosurgery for primary renal cell
carcinoma: early findings of the FASTRACK pilot study. In BJU INTERNATIONAL
(Vol. 111, pp. 47-48).
36. Hardcastle, N., Clements, N., Chesson, B., Aarons, Y., Cramb, J., Siva, S., ... & Kron,
T. (2014). Results of patient specific quality assurance for patients undergoing
stereotactic ablative radiotherapy for lung lesions. Australasian Physical &
Engineering Sciences in Medicine, March 2013, Volume 36, Issue 1, pp 65-141
37. Lonski P, Franich R, Siva S, Keehan S, Taylor M, et al. (2014) TU-F-BRE-07: In Vivo
Neutron Detection in Patients Undergoing Stereotactic Ablative Radiotherapy (SABR)
for Primary Kidney Cancer Using 6Li and 7Li Enriched TLD Pairs. Medical Physics
41: 469-469.
38. Siva, S., M. P. MacManus, T. Kron, et al. "Inflammatory Cytokine Expression as
Prognostic Biomarkers of Toxicity During Radiation Therapy of Patients With NonSmall Cell Lung Cancer." International Journal of Radiation Oncology Biology
Physics 90, no. 1 (2014): S636.
39. Siva, S., T. Devereux, N. Hardcastle, et al. "Feasibility of IMRT Planning to Reduce
Dose to Functional Lung Using Respiratory Gated (4D) Gallium-68 Perfusion
PET/CT." International Journal of Radiation Oncology Biology Physics 90, no. 1
(2014): S618-S619.
40. P Lonski, R Franich, M Taylor, D Pham, S Siva and T Kron Out-of-field in vivo
dosimetry in patients undergoing stereotactic ablative radiotherapy (SABR) for primary
kidney cancer Journal of Medical Imaging and Radiation Oncology (2014) 58, pp 68
41. P Jackson,F Foroudi, M Hofman and S Siva Change in regional renal function by
serial 99mTc-DMSA SPECT/CT in patients receiving stereotactic ablative body
C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 9

radiation therapy for primary renal cell carcinoma, Journal of Medical Imaging and
Radiation Oncology (2014) 58, pp 24
42. N Hardcastle, MS Hofman, RJ Hicks and S Siva Use of ventilation/perfusion PET
imaging in lung radiotherapy Journal of Medical Imaging and Radiation Oncology
(2014) 58, pp 78
43. K Kirby, H Caine, D Whalley and S Siva Dosimetric comparison: 3D conformal (3DCRT), intensity modulated (IMRT) and volumetric modulated arc (VMAT) stereotactic
ablative body radiotherapy (SABR) for oligometastases of the lung Journal of Medical
Imaging and Radiation Oncology (2014) 58, pp 98
44. S Siva, T Devereux, N Hardcastle et al. Functionally adapted IMRT lung planning
using respiratory-gated (4D) Gallium-68 perfusion PET/CT Journal of Medical
Imaging and Radiation Oncology (2014) 58, pp 105
45. N Hardcastle, D Pham, R Montgomery. and S Siva. Creation of an e-learning
platform for SAFRON II (TROG 13.01) clinical trial implementation, Journal of
Medical Imaging and Radiation Oncology (2014) 58, pp 128
46. D Pham, T Kron, M Bressel. And S Siva 4D image guidance and stabilisation for
stereotactic ablative body radiotherapy (SABR) treatment for primary renal cell
carcinoma (RCC), Journal of Medical Imaging and Radiation Oncology (2014) 58, pp
148
47. D Pham, A Thompson, T Kron and S Siva Stereotactic ablative body radiotherapy
(SABR) for primary renal cell carcinoma (RCC): Technique and early toxicity in a
single institution, Journal of Medical Imaging and Radiation Oncology (2014) 58, pp
149
48. S Siva, S Deb, R Young, et al. Association of post-therapy FDG-PET and pathological
biomarkers with survival after chemoradiation of locally advanced cervical cancer
Journal of Medical Imaging and Radiation Oncology (2014) 58, pp 155
49. S Siva, K Kirby, H Caine et al. An inter-institutional analysis of outcomes after single
and multi-fraction stereotactic ablative body radiotherapy (SABR) for pulmonary
oligometastases screened using FDG-PET Journal of Medical Imaging and Radiation
Oncology (2014) 58, pp 175
50. B Chesson, D Ball, M MacManus and S Siva Comparison of 3D-PET versus 4DPET for planning of small peripheral lung metastasis treated using stereotactic ablative
radiotherapy (SABR) Journal of Medical Imaging and Radiation Oncology (2014) 58,
pp 176
51. T Kron, D Pham, A Lim. and S Siva Are 6MV X-rays all it takes for SABR?
Journal of Medical Imaging and Radiation Oncology (2014) 58, pp 178
52. MacManus, Michael, Robin Anderson, Prudence Russell, Ashley Cox, Agnieszka
Swierczak, Judy P. Doherty, Daphne Jacobs et al. "Mobilization of tumor cells into the
circulation during radiation therapy for lung cancer." Cancer Research 74, no. 19
Supplement (2014): 4826-4826.
53. Peta Lonski, Rick Franich, Shankar Siva, Michael Taylor and Tomas Kron. In vivo
detection of neutrons produced during high energy radiotherapy using Li-6 and Li-7
enriched TLD pairs. Australas. Phys. Eng. Sci. Med. 37 (2014) 215. Abstract of a paper
presented at the Engineering and Physical Sciences in Medicine (EPSM) Conference,
Perth, November 3 7, 2013.
54. Daniel Pham, Tomas Kron, Colin Styles, May Whitaker, Shankar Siva and Farshad
Foroudi. A study of dual vacuum immobilisation to minimise kidney motion. Australas.

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 0

Phys. Eng. Sci. Med. 37 (2014) 221. Abstract of a paper presented at the Engineering
and Physical Sciences in Medicine (EPSM) Conference, Perth, November 3 7, 2013.
55. Tomas Kron, Dan Steinfort, Brent Chesson, Shankar Siva, Lou Irving and David Ball.
Image guidance for extracranial stereotactic radiotherapy of lung cancers using
endobronchially implanted fiducial markers. Australas. Phys. Eng. Sci. Med. 37 (2014)
154. Abstract of a paper presented at the Engineering and Physical Sciences in
Medicine (EPSM) Conference, Perth, November 3 7, 2013.
56. Nick Hardcastle, Jason Callahan, Michael Hofman, David Ball, Tomas Kron, Michael
MacManus, Rod Hicks and Shankar Siva. Quantifying change in lung perfusion over
the course of radiotherapy. Australas. Phys. Eng. Sci. Med. 37 (2014) 174-175.
Abstract of a paper presented at the Engineering and Physical Sciences in Medicine
(EPSM) Conference, Perth, November 3 7, 2013.
57. J. Supple, U.J. Yeo, S. Siva, D. Pham, T. Devereux, M.L. Taylor, T. Kron, R.D.
Franich, Deformable Image Registration Based Dose Accumulation Methods For
Kidney Arc Therapy Abstract of a paper presented at the Engineering and Physical
Sciences in Medicine (EPSM) Conference, Perth, November 3 7, 2013, 190, Springer
Netherlands
Missing in - 2014: ALCC and ESTRO
P
1.
2.
3.
4.
5.

6.
7.
8.
9.
10.

R I Z E S

W A R D S

Elekta Award best proffered paper - new technology in radiotherapy- Association of

post-therapy FDG-PET and pathological biomarkers with survival after chemoradiation
of locally advanced cervical cancer. CSM 2014 ($2,000)
Wiley-Blackwell Best Exhibit Award Radiation Oncology, Impact of stereotactic
ablative body radiotherapy on renal function after treatment of primary renal cell
carcinoma. CSM 2014 ($700)
Radiation Research Society (RADRES) Scholar-in-Training Travel Award, 2014 ASM
($700)
Victorian Comprehensive Cancer Centre PhD Student Prize, 2013, for outstanding work in
a research higher degree - $5000
Minnies 2013 Excellence in Radiology awards: Best Radiology Image 3D PET digital
reconstruction of Merkel cell carcinoma patient, AuntMinnies.com, selected by peer
voting from the publication Siva et al. "18F-FDG PET Provides High-Impact and
Powerful Prognostic Stratification in the Staging of Merkel Cell Carcinoma: A 15-Year
Institutional Experience." JNM (2013).
David Robinson Innovation Award, EPSM 2013, for abstract titled Quantifying changes
in lung perfusion over the course of radiotherapy presented by N. Hardcastle, S Siva
as senior author
Royal Australia and New Zealand College of Radiation Oncology / Ferring Pharmaceutical
Fellowship Award 2013: - $25,000
Novartis Travel Award: - Australia and New Zealand Urogenital and Prostate cancer trials
group ASM 2012
Australia and Asia Pacific Clinical Oncology Research Development Workshop (ACORD)
fellowship 2012
RANZCR Research Award Prize 2012 - $10,000 clinical trial support

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 1

11.
12.
13.
14.
15.
16.
17.
18.

National Health and Medical Research Council (NHMRC) postgraduate scholarship 2012,
APP1038399_SIVA, ($109,500)
Elekta Scholarship 2012 - $20,000 towards PhD support
Australian Lung Cancer Conference Travel Award: - ALCC conference 2012
Victorian Comprehensive Cancer Centre Young Investigator Travel Award 2011, IASLC
World Lung Conference
Hospira Peters and Withers prize for research, Royal Australia and New Zealand College
of Radiation Oncology 2011 - $25,000
Oncura Bourne and Langlands Research Prize 2010 awarded to an outstanding research
project from the RANZCR(Royal Australia and New Zealand College of Radiation
Oncology)
RANZCR Research Award Prize 2010 - $10,000 clinical trial support
Varian Travel Scholarship, RANZCR(Royal Australia and New Zealand College of
Radiation Oncology) ASM 2007, ASM 2009

G R A N T S
(Total Research Funding [with prizes] = $1,544,382)
Cancer Australia Project Grant 2014, APP1082399 Investigating the safety and efficacy,
quality of life, cost-efficiency and immune potential of high precision lung radiotherapy, CIA
S Siva - $439,418
Cancer Australia Project Grant 2013, APP1060919 - Investigation of molecular imaging
and serum biomarkers to identify lung injury and enable individualized radiation therapy for
lung cancers, joint New Investigator, M. Hofman & S Siva - $498,012
Stereotactic Ablative Body Radiosurgery for the Treatment of Breast Cancer Metastases,
F Foroudi, S David, S Siva, B Chua, C Phillips 2013 - $178,710
Varian Industries partnership research grant: 4D IGRT in Extracranial Stereotactic
Radiotherapy for Primary Renal Cell Carcinoma D Pham, T Kron, F Foroudi, S Siva, G
Duchesne - 2013, $131,000
Prostate Cancer Foundation of Australia new concept grant (Associate Investigator): A
pilot Study of patients with Oligometases from Prostate cancer treated with Stereotactic
Ablative Radiosurgery (POPSTAR) 2012 - $189,240
University of Technology Sydney (UTS) Business School Grant 2012 - An economic
evaluation of alternative follow-up regimens utilising a single post-therapy FDG-PET scan for
patients with locally advanced cervical cancer C Hou, S Siva, M Haas, R Viney - $9,922
Peter Mac Foundation New Investigator Grant 2011 A proof of concept translational
study of potential biomarkers of tumour response in 105 patients with locally advanced cervical
cancer treated with chemoradiation and receiving post-therapy positron emission tomography
- $25,000 Trial support
CASS foundation science and medicine grant: - awarded for FASTRACK pilot study
(Focal Ablative Stereotactic Radiosurgery for Cancers of the Kidney), $50,000 research
support 2011

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 2

N V I T E D

P E A K E R

O N T R I B U T I O N S

1. Invited speaker Faculty of Radiation Oncology Genitourinary Group (FROGG)

Stereotactic Body Radiotherapy Workshop 2014, Stereotactic Radiotherapy for Renal
Cell Carcinoma
2. Invited speaker Clinical Oncology Society of Australia, Advanced Trainees Weekend
Program Everything You Need To Know About Lung Cancer, 2014 Stereotactic Lung
Radiotherapy
3. Invited speaker Newcastle Mater / Astra Zeneca combined urogenital meeting Stereotactic ablative body radiotherapy (SABR): state-of-the-art radiation for the
management of primary and oligometastatic RCC
4. Invited panel discussant Combined Scientific Meeting 2014 ESTRO: Personalizing
ablative therapy for oligo-metastatic disease, Melbourne
5. Invited speaker Australian standards for SBRT/SABR A tripartite approach, CSM
2014
6. Invited speaker Royal Adelaide Hospital oncology academic meeting, Stereotactic
radiotherapy for thoracic cancers 2014
7. Invited speaker Pursuing a Post-Fellowship Higher Research Degree, Radiation
Oncology trainee forum, CSM 2014
8. Invited Panel Chair ANZUP ASM 2014 Renal Cell Masterclass, Melbourne
9. Invited Session Chair ANZUP ASM 2014 Best-of-the-best Oral Abstracts,
Melbourne
10. Invited speaker RANZCR ASM 2013 Stereotactic Radiotherapy for Pulmonary
Oligometastases, Auckland NZ
11. Invited speaker Peter Mac / Astra Zeneca educational dinner Stereotactic Ablative
Body Radiotherapy for the management of Primary Renal Cell Carcinoma
12. Invited speaker Radiation Oncology Queensland (ROQ) Thoracic Forum Stereotactic
Ablative Body Radiotherapy in Thoracic Oncology, Brisbane, 2013
13. Invited speaker Australian and New Zealand Urogenital and Prostate (ANZUP) ASM
New Treatment Paradigms in Oligometastatic Disease, Gold Coast, 2013
14. Invited panel discussant, Australian and New Zealand Urogenital and Prostate (ANZUP)
ASM A giant leap II: renal cell cancer and bladder cancer, Gold Coast 2013
15. Invited Speaker, International Conference on Computing in Radiotherapy, Teaching
session update Functional Imaging in Radiotherapy, 2013
16. Peter MacCallum Cancer Centre, Grand Rounds 2013, The Stereotactic Ablative Body
Radiotherapy (SABR) program at Peter Mac at the cutting edge of radiotherapy
17. Invited Speaker, North Coast Cancer Conference 2013 The role of stereotactic ablative
body radiotherapy (SABR) in the modern oncology practice
18. Invited panel discussant, Australian and New Zealand Urogenital and Prostate (ANZUP)
Cancer Trials Group Renal Cell Carcinoma Masterclass 2013
19. Invited panel discussant TROG ASM 2013 technical research workshop
20. Invited speaker RANZCR ASM 2012 Stereotactic Radiotherapy for Pulmonary
Oligometastases and Stereotactic Radiotherapy for Renal Cell Carcinoma
21. Invited speaker RANZCR ASM 2012 - The role of functional positron emission
tomography (PET) imaging in cancer response assessment

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 3

22. Invited speaker FROGG High-Risk Prostate Cancer Workshop 2012 Stereotactic
Ablative Body Radiotherapy In Oligometastatic Genitourinary Cancer
23. Invited Speaker, National Bladder and Kidney Cancer Symposium 2012: Stereotactic
Radiosurgery for Renal Cell Carcinoma
24. Invited Speaker, MSCV 2012, Medical Student Council of Victoria Annual Academic
Forum, Stereotactic Ablative Body Radiotherapy the Next Generation of Radiotherapy
25. Invited Panel Discussant, Renal Cell Carcinoma, ANZUP 2012
26. Invited speaker, Stereotactic Body Radiotherapy workshop 2011, Melbourne, Victoria
27. Invited speaker, PMCC Grand Rounds:- October 2011 Early Experience of Stereotactic
Radiotherapy for Lung Oligometastases
P

O D I U M

O N F E R E N C E

R E S E N T A T I O N S

28. Oral Presentation, Australasian Lung Cancer Conference, 2014, Use of 4D

ventilation/perfusion (V/Q) PET/CT for adaptive intensity modulated radiotherapy
(IMRT), Gold Coast
29. Oral Presentation, Combined Scientific Meeting (CSM) 2014, An inter-institutional
analysis of outcomes after single and multi-fraction stereotactic ablative body radiotherapy
(SABR) for pulmonary oligometastases screened using FDG-PET, Melbourne
30. Oral Presentation, Combined Scientific Meeting (CSM) 2014, Functionally adapted IMRT
lung planning using respiratory-gated (4D) Gallium-68 perfusion PET/CT, Melbourne
31. Oral Presentation, Combined Scientific Meeting (CSM) 2014, Association of post-therapy
FDG-PET and pathological biomarkers with survival after chemoradiation of locally
advanced cervical cancer, Melbourne
32. Oral Presentation, ESTRO 33 ASM 2014, Impact of imaging and pathological biomarkers
on survival after chemoradiation of locally advanced cervical cancer
33. Oral Presentation, IASCLC World Congress in Lung Cancer, 2013 Four-dimensional
Gallium-68 perfusion PET/CT scans can improve radiotherapy planning through functional
avoidance of lung
34. Oral Presentation, IASLC World Congress in Lung Cancer, 2013 Response Assessment of
Stereotactic Ablative Body Radiotherapy (SABR) for pulmonary metastases: utility of 4DFDG-PET and CT-perfusion
35. Oral Presentation, RANZCR ASM 2013 Four-dimensional Gallium-68 perfusion
PET/CT scans can improve radiotherapy planning through functional avoidance of lung
36. Oral presentation, best of the best session, Urological Society of Australia and New
Zealand (USANZ) 2013 Feasibility and Tolerability of Stereotactic Radiosurgery for
Primary Renal Cell Carcinoma: Early Findings of the FASTRACK Pilot Study
37. Oral presentation ASTRO 2012: - FDG-PET Scanning has a High Impact on the
Management of Patients with Merkel Cell Carcinoma
38. Oral presentation ASTRO 2012: Routine Follow-up Rarely Detects Disease Recurrence
after a Complete Response on FDG-PET in Patients with Locally Advanced Cervical
Cancer
39. Oral Presentation: - Australian Lung Cancer Conference 2012 Response assessment of
Stereotactic Ablative Body Radiotherapy (SABR) for pulmonary metastases: utility of 4DFDG-PET and CT perfusion
40. Oral Presentation: - Australian Lung Cancer Conference 2012 Preliminary experience of
a prospective pilot study of Gallium-68 VQ 4D-PET/CT in lung radiotherapy
C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 4

41. Oral presentation: - ESTRO 2012: - Long terms outcomes of prospective study of posttherapy positron emission tomography in patients with locally advanced cervical cancer
42. Oral presentation new proposal, Technical workshop, TROG ASM 2012: A randomized
phase II trial of stereotactic radiotherapy vs radiosurgery for oligometastates to the lung
43. Oral Presentation; - European Society of Gynaecology Oncology ASM 2011 PostTherapy FDG-Pet may obviate the need for hospital based follow-up after chemoradiation
of cervical cancer -Chairmans selection for best speaker at session :
44. Oral presentation: - Varian Prize education session 2011 RANZCR ASM: - Early
experience of stereotactic ablative frameless radiosurgery for oligometastatic neoplasia to
the lung
45. Oral Presentation, PMCC Seminars in Oncology September 2011 A Basic Guide to
Stereotactic Lung Radiotherapy
46. Oral presentation: -Varian Prize Education session: -2010 RANZCR ASM - PostTherapy FDG-Pet may obviate the need for hospital based follow-up after chemoradiation
of cervical cancer
P

O S T E R

O N F E R E N C E

R E S E N T A T I O N S

47. Poster Presentation ALCC CSM 2014 Outcomes of Single vs Multi-Fraction SABR
for Pulmonary Oligometastases Screened by FDG-PET
48. Poster Presentation, ASTRO 56 ASM, 2014 Inflammatory Cytokine Expression as
Prognostic Biomarkers of Toxicity During Radiation Therapy of Patients with Non-Small
Cell Lung Cancer
49. Poster Presentation, Radiation Research Society ASM 65, 2014 "Radiation-induced
inflammatory plasma cytokines are associated with lung toxicity in patients with nonsmall cell lung cancer", Las Vegas, NV
50. Poster Presentation, ASTRO 56 ASM, 2014 Feasibility of IMRT Planning to Reduce
Dose to Functional Lung Using Respiratory Gated (4D) Gallium-68 Perfusion PET/CT
51. Poster Presentation, Combined Scientific Meeting ASM 2014, A stereotactic ablative
body radiotherapy (SABR) program founded on clinical trials: A report of the first 100
patients treated in an Australian academic institution, Melbourne
52. Poster Presentation, Combined Scientific Meeting ASM 2014, Impact of stereotactic
ablative body radiotherapy on renal function after treatment of primary renal cell
carcinoma, Melbourne
53. Poster Presentation, Lorne Cancer Conference 2014 Inflammatory Cytokine Expression
During Radiation Therapy of Patients with Non-Small Cell Lung Cancer
54. Poster Presentation, IASCLC World Congress in Lung Cancer, 2013 DNA Damage
Response during Curative Radiotherapy of Non-Small Cell Lung Cancer: In-Vivo
Biodosimetry with Peripheral Blood Lymphocytes and Systemic Effects Measured in
Hair Follicles
55. Poster Presentation, Australian and New Zealand Urogenital and Prostate (ANZUP)
ASM An Early Report of Tolerability of Stereotactic Ablative Body Radiotherapy for
Primary Renal Cell Carcinoma, Gold Coast, 2013
56. Poster Presentation, Lorne Cancer Conference 2013 DNA Damage Response in
Peripheral Blood Lymphocytes and Out-of-Field Hair Follicles During Radical
Radiotherapy of Non-Small Cell Lung Cancer

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 5

57. Poster presentation ASTRO 2012: Analysis of Potential Surrogates for Kidney Motion
Verification Imaging and its Implications for Stereotactic Radiotherapy of the Kidney
58. Poster Presentation, ANZUP 2012 A systematic review of stereotactic radiotherapy
ablation for primary renal cell carcinoma

O N S U L T A N C I E S

Tripartite committee (RANZCR, APSEM, AIR) steering committee for national guidelines
in stereotactic ablative body radiotherapy, 2014

E A C H I N G

A N D

U P E R V I S I O N

PhD Supervisory board Daniel Pham, Radiation Therapist, 2013 - 2015

M E D I A

N V O L V E M E N T

PET S C A N S C L E A R H U R D L E F O R M E R K E L C E L L D X M E D P A G E T O D A Y
2012, H T T P :// W W W . M E D P A G E T O D A Y . C O M /M E E T I N G C O V E R A G E /ASTRO/35673
PET S C A N S C H A N G E M A N A G E M E N T O F P A T I E N T S W I T H M E R K E L C E L L
C A R C I N O M A H T T P :// W W W . D O C G U I D E . C O M / P E T - S C A N S - C H A N G E - M A N A G E M E N T P A T I E N T S - M E R K E L - C E L L - C A R C I N O M A ? T S I D =5
PET H E L P S M O D I F Y T R E A T M E N T F O R M E R K E L C E L L C A R C I N O M A , 2012
H T T P :// W W W . S M A R T B R I E F . C O M / N E W S / S N M M I / S T O R Y D E T A I L S . J S P ? I S S U E I D =5B2F
B5CD-613A-4727-B872-D2CEAC75A161& C O P Y I D =39261836-E06C-4680B366-AE5C0D41B102
PET S C A N S R E D U C E N E E D F O R F O L L O W - U P A F T E R C E R V I C A L C A N C E R
T O N Y J A M E S , O N C O L O G Y U P D A T E M A R C H 2011 H T T P :// W W W . O N C O L O G Y U P D A T E . C O M . A U / G E T A T T A C H M E N T / F 3765 D 1 A -85 F 7-4 A 1889 E B - B 0 B 2 B 635 E 234/ P D F . A S P X
PET I M A G I N G M A Y P R E D I C T C E R V I C A L C A N C E R O U T C O M E . - S E P T E M B E R
2011, ASCO N E W S ,
H T T P :// M A I L V I E W . B U L L E T I N H E A L T H C A R E . C O M / M A I L V I E W . A S P X ? M =2011091901 A S C
O & R =4257819- A 517
T H E AGE D E C 16 2011, P A G E 9 : S I G N I N G T O S E A L C A N C E R C E N T R E P L A N /
S H A R P E N I N G T H E L A S E R : NHMRC P O S T G R A D U A T E S C H O L A R S H I P
H T T P :// W W W . P E T E R M A C . O R G / N E W S / S H A R P E N I N G - L A S E R - P E T E R - M A C - C L I N I C I A N S REFINING-RADIATION-THERAPY-PERSONALISE-LUNG-CANCER
T H E AGE A P R I L 28 T H 2012: - N E W

HOPE FOR LUNG

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 6

CANCER PATIENTS

 T H E H E R A L D S U N , M A R C H 13 T H 2013:
- P L A S T I C K E Y T O C A N C E R
THERAPY
H T T P :// W W W . H E R A L D S U N . C O M . A U / N E W S / V I C T O R I A / P L A S T I C - K E Y - T O - C A N C E R T H E R A P Y / S T O R Y - E 6 F R F 7 K X -1226596711270
PETER M A C 2012 AGM V I D E O T H A T S W H Y I M H E R E
AUNT MINNIE B E S T R A D I O L O G Y E N T R Y 2013 A W A R D M E R K E L C E L L
C A R C I N O M A H T T P :// W W W . A U N T M I N N I E . C O M / I N D E X . A S P X ? S E C = S U P & S U B = C T O &
P A G = D I S &I T E M ID=105242
TH

ABC

N A T I O N A L N E W S 28
O C T O B E R 2013 W O R L D L U N G C A N C E R
CONFERENCE PRESENTATION
H T T P :// W W W . A B C . N E T . A U / N E W S /2013-10-28/ W O R L D - F I R S T -4 D - C A N C E R I M A G I N G - C A N - B E - T A I L O R E D - T O - I N D I V I D U A L S /5048954

H T T P :// W W W . Y O U T U B E . C O M / W A T C H ? V =W D G99S V G F B Y

H E R A L D S U N , W O R L D F I R S T L U N G T E S T S U S I N G 4D S C A N S A I D C A N C E R
TH
F I G H T , O C T 28
2013
H T T P :// W W W . H E R A L D S U N . C O M . A U / N E W S / V I C T O R I A / W O R L D F I R S T - L U N G - T E S T S U S I N G -4 D - S C A N S - A I D - C A N C E R - F I G H T / S T O R Y - F N I 0 F I T 3-1226747849120
AUSTRALIAN LUNG CANCER
N O N -P E E R

FOUNDATION,

REVIEWED

I N F O R M A T I O N DVD - 2014

PUBLICATIONS:

Research Higher Degrees: Inside News, Quarterly publication of the Royal

Australasian and New Zealand College of Radiologists.
Clinician Scientist Pathway: Inside News, Quarterly publication of the Royal
Australasian and New Zealand College of Radiologists.

C U R R I C U L U M V I T A E D R S H A N K A R S I V A , P A G E 1 7